SMAD2 and metabolic dysfunction-associated steatohepatitis: Among these, the activation of SMAD2, SMAD4, YAP1, NOTCH1, EP300, p63, and the inhibition of nuclear receptor corepressor (NCOR) has been previously linked to human NASH by independent studies (Table 3) [42,166,173,209,210,211,212].